Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,400.00 at Evercore ISI

Mettler-Toledo International (NYSE:MTD) had its price target upped by Evercore ISI from $1,275.00 to $1,400.00 in a research note issued to investors on Tuesday,Benzinga reports. Evercore ISI currently has an outperform rating on the medical instruments supplier’s stock.

A number of other equities research analysts have also recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Saturday, September 27th. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Barclays lifted their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a research note on Thursday, October 2nd. Robert W. Baird lifted their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Finally, Bank of America lifted their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $1,342.22.

Mettler-Toledo International Stock Down 2.9%

MTD stock opened at $1,305.67 on Tuesday. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,486.76. The business has a fifty day moving average of $1,274.75 and a two-hundred day moving average of $1,187.87. The stock has a market cap of $26.90 billion, a price-to-earnings ratio of 33.06, a price-to-earnings-growth ratio of 4.04 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million during the quarter, compared to analysts’ expectations of $957.41 million. During the same period in the previous year, the firm posted $9.65 earnings per share. The company’s revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company’s stock, valued at $368,154.70. The trade was a 78.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider directly owned 94 shares of the company’s stock, valued at $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,827 shares of company stock worth $2,371,208. Company insiders own 0.77% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of institutional investors have recently bought and sold shares of the business. Assenagon Asset Management S.A. lifted its holdings in Mettler-Toledo International by 13.7% during the 3rd quarter. Assenagon Asset Management S.A. now owns 19,935 shares of the medical instruments supplier’s stock worth $24,472,000 after buying an additional 2,408 shares during the last quarter. Union Bancaire Privee UBP SA lifted its holdings in Mettler-Toledo International by 17.7% during the 3rd quarter. Union Bancaire Privee UBP SA now owns 332 shares of the medical instruments supplier’s stock worth $400,000 after buying an additional 50 shares during the last quarter. Aaron Wealth Advisors LLC purchased a new stake in Mettler-Toledo International during the 3rd quarter worth about $351,000. GAMMA Investing LLC lifted its holdings in shares of Mettler-Toledo International by 1.6% in the 3rd quarter. GAMMA Investing LLC now owns 510 shares of the medical instruments supplier’s stock valued at $626,000 after purchasing an additional 8 shares during the last quarter. Finally, Corient Private Wealth LLC lifted its holdings in shares of Mettler-Toledo International by 91.8% in the 2nd quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.